HCL - Centre Hospitalier Lyon Sud

Pierre-Bénite, Auvergne-Rhône-Alpes 69495

0 studies enrolling now · 2 studies all time

What they study most

Biochemically Recurrent Prostate Cancer, Cancer

Studies at this site

• Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer — Running, not enrolling
• A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies — Running, not enrolling